Introduction
Populations of elderly patients with advanced heart failure (HF) and chronic obstructive pulmonary disease (COPD) are growing. In Sweden, the prevalence of HF is estimated at 10 % for those ≥ 80 years old 1 , and the prevalence of COPD is already 8 % at 50 years, and increases by age 2 . Dyspnea is a characteristic feature of both diseases, which initially is exertional and, as the diseases progress, appears at rest as well. Edema is associated with HF, and patients with COPD demonstrate chronic cough which often is associated with increased mucus production. Both diseases may demonstrate episodes of worsening symptoms, known as exacerbations. 3, 4 Patients with HF and/or COPD often wait to seek medical help in the early phases of deterioration, which usually leads to hospitalization as patients' conditions demand a more comprehensive medical procedure 5, 6 . This is very costly and it is estimated that a 10 % annual reduction of the number of COPD exacerbations occurring in Sweden would save approximately €50 million annually 7 .
New technology can be a barrier for elderly, severely ill patients with little or no experience of computers, tablets, smartphones, or technology in general; therefore, easeof-use concerning technology is essential 8, 9 . To facilitate reporting, a digital pen technology has been used successfully in elderly palliative patients with end-stage cancer or advanced HF for the frequent assessment and reporting of symptoms, measurements, and intake of rescue medications to a HBHC unit [10] [11] [12] [13] .
During the last 10-15 years, there has been a growing number of original telehealth studies and reviews including patients with HF and/or COPD [14] [15] [16] [17] [18] [19] [20] [21] [22] [23] [24] [25] [26] [27] [28] [29] . The focus of most of these studies has been to investigate if the use of a telehealth system can reduce disease related hospitalizations. The current study focused on all-cause hospitalizations, but also included emergency room visits, primary care visits, other outpatient care, and healthcare costs. Therefore, this study was designed to illustrate a more detailed analysis of costs and resources being used in a telehealth intervention. The aim in this study was to investigate the effects of the telehealth intervention on healthcare costs and the number of hospitalizations, as well as other care, in severely ill elderly patients with HF or COPD.
Methods

Setting and usual care
The eHealth Diary study was performed at the HBHC unit, Linköping University Hospital. The clinic provides specialized homecare to patients with advanced HF and/or COPD. The treatment period depends on the patient's condition, and, in usual care before the study, patients are discharged to primary care when they are stable with respect to HF/COPD. During the study period, as long as a patient participated in the eHealth Diary study, he/she was not discharged from the HBHC unit. However, all study patients had to consult primary care or other care providers for health conditions not related to HF or COPD.
Study design
The Health Diary system enables patients to report their daily health status, such as symptoms and measurement values, and intake of as-needed medication using a digital pen and a Health Diary paper form, and it supports professional caregivers in detecting early signs of patients' deterioration. The Health Diary system was designed, developed, tested, and implemented in collaboration with researchers, care providers at the HBHC unit and the software company Phoniro AB, Sweden. Assigned physicians and nurses at the HBHC unit supervised the system daily and provided most of the care needed. If a patient failed to send in his/her daily report the Health Diary system generated an SMS alarm the next morning. Likewise, if the care providers forgot to check and sign a patient report that had generated an alarm, the system sent an SMS alarm the next morning. Patient reports with values within the predetermined individual limits were to be checked and signed after a maximum of two weeks and if the care providers failed to do this the system generated alarms (both SMS and shown in the web application).
Data collection
Patients aged 65 years or older who visited the emergency department at Linköping University Hospital due to exacerbation for either COPD or HF with a history of at least two inpatient episodes the last twelve months, were invited to participate in the study.
Patients with inpatient care at other departments at Linköping University Hospital who met the inclusion criteria could also be recruited, as could patients in primary care if their HF or COPD condition worsened, and if they met the inclusion criteria. Exclusion criteria comprised dementia, other cognitive impairment or psychotic illness, not able to understand the Swedish language, severe hearing loss, past surgery the last 6 months or planned within 6 months ahead, or other life-threatening illness. Patients were recruited until the number needed to study was reached (n=65 in each group) due to the sample size calculation (a power of 80%, alpha 0.05 and a difference of 15% between actual and expected outcomes). To ensure similar conditions for the study patients, an inclusion period of three years was used with a planned study period of twelve months for each patient, leading to a four-year study (November 2013-December 2017). Data on healthcare contacts (inpatient and outpatient) as well as direct healthcare costs were collected for each patient for one year or to date of death. All use of healthcare resources and costs, not only HF or COPD related, were considered, as HF and COPD are systemic disorders that can cause hospitalization for various reasons. The responsible physician identified patients' exacerbations and documented these in the electronic health record.
Using the unique 10-digit Swedish personal identity number, patient data were linked to the Care Data Warehouse in Östergötland (CDW) and Cost Per Patient database (CPP). The CDW includes all healthcare contacts (inpatient, outpatient, and primary care) for both private care and public care, and CPP includes costs for all contacts within public care.
For an adequate assessment of cost data, all costs collected from CPP were discounted with 3 % per year up to the year 2017 and converted to euros (1 euro = 10 SEK). Costs were missing in 14 % of all contacts, mainly because of care given by private primary care providers. For these contacts, healthcare costs were imputed with the average cost calculated per contact type for existing data. Contact types with medical professionals were inpatient care, physician visit, district nurse visit, registered nurse visit, and visit to nurse assistant. Less than 1 % of contacts with missing costs were related to inpatient care.
Contacts with health services were grouped into inpatient care, emergency care, primary care, other outpatient care, and care provided by the HBHC unit. Patients receiving inpatient care and emergency care within two weeks before inclusion in the study were not included as they are major influences in the pre-study year and would, if they were included, overestimate the predicted expected value for the study year.
Statistical analysis
In this cohort study actual outcome data were compared to expected outcome data;
the expected values were based on a 5-year history on the studied group. The primary outcomes were number of hospitalizations and total healthcare costs. The secondary outcomes were number of contacts with emergency care, primary care, other outpatient care, and the HBHC unit.
Expected use of healthcare resources and healthcare costs at study year were calculated using the generalized estimating equations (GEE) method. Poisson distribution with a log link was used for healthcare resources. For healthcare costs a gamma distribution or a normal distribution with a log link was chosen based on which one gave the best fit for actual data. For both healthcare resources and healthcare costs, repeated measures were considered and the covariance matrix was estimated using the robust estimator method. An unstructured or exchangeable working correlation matrix was chosen based on which one gave the best fit to actual data. To get the best fit to data, separate analysis models were used for HF and COPD groups. For each patient group, expected use of healthcare resources and healthcare costs was calculated for 1.
Inpatient care, 2. Emergency care, 3. Primary care, 4. Other outpatient care, and 5. Total healthcare resources/costs. For all models, the expected value at the study year was predicted using five-year data prior to the study year. To get a p-value for the ratio between the actual value and the expected value, a dichotomous variable with the value 1 at study year and 0 for non-study year was used in all models.
A t-test was used to test the proportion of death and follow-up time between the two patient groups. Chi-Square test was used for categorical data and median test to evaluate medians between groups.
As a sensitivity analysis, the number of hospitalizations and total healthcare costs were evaluated for patients completing the entire study period.
Results
Ninety-eight patients fulfilled the inclusion criteria and were asked to participate in the study. Three patients with HF and one patient with COPD declined to participate, giving a total of 94 patients: 58 patients with HF and 36 patients with COPD participated in the study which continued between November 2013 and December 2017 ( Table 1) For the HF group, the average use of healthcare resources without HBHC during the study year was 18.6 contacts (visits and hospitalizations) and this was significantly lower than expected (p<0.001) 66 % ( Table 2 , Fig. 1 ). All contact types, inpatient care, emergency care, primary care, and other outpatient care were significantly lower than expected. The average use of healthcare resources including HBHC was 55.8 contacts and this was 1 % higher than expected, although this was not significant (p=0.94). The average total healthcare cost including HBHC was €21 515; this was 20 % lower than expected, although not significant (p=0.10) ( Table 2 , Fig.2 ).
For the COPD group, the average number of healthcare contacts without HBHC during the study year was 14.3 contacts and this was significantly lower than expected (p<0.001) 60 % ( Table 2 , Fig. 1 ). All contact types except other outpatient care were significantly lower than expected. The average number of contacts including HBHC was 71.2 contacts and this was twice as high as expected (p=0.001). The average total healthcare cost including HBHC was €33 862 and this was 25 % higher than expected, although not significant (p=0.20) ( Table 2 , Fig.2 ).
During the study year, the average cost for HBHC contributed with about 60 % of total healthcare cost in both HF and COPD groups. The use of HBHC care was higher in the COPD group and contributed to 80 % of total contacts compared with 67 % in the HF group.
The sensitivity analysis showed that for patients completing the entire study period, the number of hospitalizations was 0.94 for HF and 1.16 for COPD. This was significantly lower than expected, with 67 % in the HF group (p<0.001) and 61 % in the COPD group (p=0.003). For patients completing the entire study period, total healthcare costs were €25 326 in HF patients and €42 541 in COPD patients. This was not significantly different from expected (expected value = €23 841, p=0.72) in HF patients, but in COPD patients the total healthcare cost was twice as high as expected (expected value = €20 981, p<0.001); this was mainly due to additional HBHC utilization.
Discussion
The present study shows that daily telemonitoring for patients using an easy-to-handle digital pen and a Health Diary form, and a web-based application supervised by a specialized HBHC unit which is largely responsible for care provision, lowers the need of hospital care and primary care. Also, this study shows that total healthcare costs does not increase although patients frequently use care resources from the HBHC unit.
A Cochrane meta-analysis showed that HF-related hospitalization was significantly reduced using a telemonitoring system 15, 16 . The present study demonstrates that the total number of hospitalizations were significantly lower than expected for both HF and COPD. The overall picture on how hospitalization is affected by a telemonitoring system in COPD patients seems to be ambiguous. This is illustrated by two systematic reviews showing that most studies found a positive result for the telemonitoring group, but also that some studies demonstrated a significantly increased number of hospitalizations in the intervention group. 14, 28 The use of different telehealth methodology is of importance in explaining the varying results, but also COPD patients are a heterogeneous group, and results may have been affected by different inclusion criteria in age, disease stage and need of palliative care 14 .
A Cochrane analysis for HF patients showed significantly reduced mortality for patients in the telemonitoring group 15 . In the present study, about one in three patients died within the study year, but the study design was not able to assess if this was lower than expected. A meta-analysis for COPD demonstrated no significant difference in mortality between a telephone support group and usual care 28 . The mortality in the present study was higher than in most published studies from the meta-analysis, but this is probably due to higher rates of inclusion for patients with advanced stages of disease.
Unfortunately, we did not manage to recruit the number of patients estimated from the sample-size calculation within the inclusion period of three years. However, the effects were larger than we expected, resulting in significant outcomes.
Digital and other technology solutions in healthcare are important tools for the development of healthcare in general. There is a need to speed up the research in this area, otherwise there is a risk that decisions will be made without evidence from published peer review studies. One way to speed up research is to increase the use of existing historical data to estimate expected outcomes to compare with actual outcomes.
The design of the eHealth Diary study used the study patients' historical data to estimate an expected outcome, which makes it possible to evaluate an intervention effect when randomization is not suitable. For this study there were two main reasons why this design was the most suitable. First, to ensure that the circumstances for the study patients were as similar as possible we needed to use one particular HBHC unit.
Second, there was an ethical aspect of withholding treatment from suitable patients.
The mortality rate was high in this study. However, mortality was not an explanation of the decrease in the number of hospitalizations, as this outcome was similar when analyzing solely those who completed their 12-month study period. COPD patients who completed the entire study period accessed more HBHC care compared to the main analysis, which was not the case in HF patients. This might indicate that, despite the extensive telemonitoring, elderly patients with severe COPD are in need of extra personal care compared to HF patients.
Results show that the intervention using an active telemonitoring system was effective for both HF and COPD patients in reducing hospitalizations for patients who died during the study period as well as for patients surviving the entire study period.
Furthermore, the intervention reduced the number of visits to primary care, emergency care, and other outpatient care. The reduction in such health care contacts is presumably experienced as positive in elderly people's everyday life and that aspect will be explored in a further investigation of this study group.
The method using existing historical data instead of a randomized trial, in elderly patients with chronic disease, has many strengths. For instance, it is easier to initiate the study and a higher proportion of patients participate in the intervention because no control group is needed. However, an obvious limitation with this approach compared to a randomized trial is that mortality changes due to the intervention cannot be assessed, which makes the method inappropriate if mortality is the primary outcome.
One precondition for a telemonitoring system to contribute to a lowering in hospital care is that both professional care providers and patients are familiar with the technology and use it, i.e., they are compliant in sending (patients) and checking (care providers) reports. Nakamura et al. conclude that the speed of decision making and frequency of monitoring are the two most important factors for determining effectiveness of remote patient monitoring. With a high monitoring frequency the care providers will be able to capture changes in the patient's health status with greater sensitivity 30 . The patients in our study had little or no experience of using computers or smartphones but they quickly accepted and managed to handle the digital pen for daily reporting of their health status, and the HBHC unit managed to integrate the Health Diary system in daily clinical use. This was also the case in our previous pilot study with HF patients who continued to send in daily reports during several months without receiving any home visits from the care providers as long as their HF were in a stable phase 10 . In two earlier studies we let palliative cancer patients in their end-of-life use the same technology for frequent reporting (2-3 times per day) of symptoms and intake of pain medication 12, 31, 32 . One of the studies, an randomized controlled trial, comprised four palliative care centers in different areas in Sweden, and results showed a significant shorter median time span from reporting (patients) to noticing (care providers) in the intervention group (54 minutes) compared to the control group (47 hours). Thus, patients in the intervention group were more likely to receive a quicker medical response 32 . A patient receiving quicker medical response in his/her home has also an increased chance of remaining at home instead of going to the hospital.
The results from this study show that the Health diary intervention was successful in patients with advanced COPD or HF and other similar patient groups are likely to benefit from the intervention as well. In addition, the results may be generalized to other health care systems with a well-developed home care system.
Conclusion
A telemonitoring system, the Health Diary, combined with HBHC decreases the need for hospital care in elderly patients with advanced HF or COPD without increasing total healthcare costs. 
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